Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens

  • Naoe Goto
  • , Hisashi Tsurumi
  • , Senji Kasahara
  • , Nobuhiro Kanemura
  • , Takeshi Hara
  • , Ichiro Yasuda
  • , Masahito Shimizu
  • , Nobuo Murakami
  • , Michio Sawada
  • , Toshiki Yamada
  • , Masao Takemura
  • , Mitsuru Seishima
  • , Yusuke Kito
  • , Tsuyoshi Takami
  • , Hisataka Moriwaki

Research output: Contribution to journal › Article › peer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology